Cognition Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying

Cognition Therapeutics和其他兩隻低於2美元的股票內部人士正在買入

Benzinga · 03/15 19:13

The Dow Jones index closed lower by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Blue Star Foods

The Trade: Blue Star Foods Corp. (NASDAQ:BSFC) Director Nubar Herian acquired a total of 219,611 shares an average price of $0.14. To acquire these shares, it cost around $30,636.
What's Happening: On Feb. 21, Blue Star Foods signed a master service agreement with a seafood value added provider.
What Blue Star Foods Does: Blue Star Foods Corp is an international seafood company based in Miami. It imports, packages, and sells refrigerated pasteurized crab meat, and other premium seafood products.

Ekso Bionics

The Trade: Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Director Corinna Lathan acquired a total of 13,733 shares at at an average price of $1.13. To acquire these shares, it cost around $15,477.
What's Happening: On March 4, Ekso Bionics reported mixed fourth-quarter financial results.
What Ekso Bionics Does: Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets.

Cognition Therapeutics

The Trade: Cognition Therapeutics, Inc. (NASDAQ:CGTX) CEO and President Lisa Ricciardi acquired a total of 5,700 shares at an average price of $1.75. The insider spent around $9,975 to buy those shares.
What's Happening: Cognition Therapeutics announced closing of $11.5 million public offering of common stock.
What Cognition Therapeutics Does: Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.

Don't forget to check out our premarket coverage here

The Dow Jones index closed lower by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週四收盤下跌超過100點。當內部人士購買或出售股票時，這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將此視爲他們整體投資或交易決策的一個因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是近期一些值得注意的細價股內幕交易。欲了解更多，請查看 本辛加的內幕交易 平台。

Blue Star Foods

藍星食品

The Trade: Blue Star Foods Corp. (NASDAQ:BSFC) Director Nubar Herian acquired a total of 219,611 shares an average price of $0.14. To acquire these shares, it cost around $30,636.
What's Happening: On Feb. 21, Blue Star Foods signed a master service agreement with a seafood value added provider.
What Blue Star Foods Does: Blue Star Foods Corp is an international seafood company based in Miami. It imports, packages, and sells refrigerated pasteurized crab meat, and other premium seafood products.

交易：藍星食品公司（納斯達克股票代碼：BSFC）董事努巴爾·赫裏安 共收購了219,611股股票 平均價格爲0.14美元。收購這些股票的成本約爲30,636美元。
發生了什麼：2月21日，藍星食品與一家海鮮增值供應商簽署了主服務協議。
藍星食品做什麼：藍星食品公司是一家總部位於邁阿密的國際海鮮公司。它進口、包裝和銷售冷藏巴氏消毒蟹肉和其他優質海鮮產品。

Ekso Bionics

Ekso Bionics

The Trade: Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Director Corinna Lathan acquired a total of 13,733 shares at at an average price of $1.13. To acquire these shares, it cost around $15,477.
What's Happening: On March 4, Ekso Bionics reported mixed fourth-quarter financial results.
What Ekso Bionics Does: Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets.

交易：Ekso Bionics Holdings, Inc.（納斯達克股票代碼：EKSO）董事科琳娜·拉森 共收購了13,733股股票 平均價格爲1.13美元。收購這些股票的成本約爲15,477美元。
發生了什麼：3月4日，Ekso Bionics公佈的第四季度財務業績喜憂參半。
Ekso Bionics做什麼：Ekso Bionics Holdings Inc設計、開發和銷售用於醫療保健和工業市場的外骨骼技術。

Cognition Therapeutics

認知療法

The Trade: Cognition Therapeutics, Inc. (NASDAQ:CGTX) CEO and President Lisa Ricciardi acquired a total of 5,700 shares at an average price of $1.75. The insider spent around $9,975 to buy those shares.
What's Happening: Cognition Therapeutics announced closing of $11.5 million public offering of common stock.
What Cognition Therapeutics Does: Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.

交易：Cognition Therapeutics, Inc.（納斯達克股票代碼：CGTX）首席執行官兼總裁麗莎·裏查迪 共收購了5,700股股票 平均價格爲1.75美元。知情人士花費了約9,975美元購買了這些股票。
發生了什麼：Cognition Therapeutics宣佈完成1150萬美元的普通股公開發行。
Cognition Therapeutics做什麼：Cognition Therapeutics Inc是一家臨床階段的生物製藥公司，致力於發現和開發針對年齡相關退行性疾病以及中樞神經系統和視網膜障礙的創新小分子療法。

Don't forget to check out our premarket coverage here

別忘了在這裏查看我們的上市前報道

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。